1. Type of vascular access and mortality in U.S. hemodialysis patients
Rajnish K. Dhingra, Eric W. Young, T.E. Hulbert-Shearon, Sean F. Leavey, Friedrich K. Port 
Kidney International 
Volume 60, Issue 4, Pages (October 2001)
DOI: /j x
Copyright © 2001 International Society of Nephrology Terms and Conditions

2. Figure 1
Adjusted patient survival (Cox)* for various vascular access (VA) types [arteriovenous fistula (AVF); arteriovenous graft (AVG); central venous catheter (CVG)] in prevalent diabetic patients. *Adjusted for the average diabetic patient overall (Cox). Covariates in the model included age, race, gender, body mass index (BMI), history of smoking, peripheral vascular disease (PVD), coronary artery disease (CAD), chronic heart failure (CHF), neoplasm, ability to ambulate, and education level.
Kidney International  , DOI: ( /j x)
Copyright © 2001 International Society of Nephrology Terms and Conditions

3. Figure 2
Adjusted patient survival (Cox)* for various VA types in prevalent nondiabetic patients. *Adjusted for the average diabetic patient overall (Cox). Covariates in the model included age, race, gender, BMI, history of smoking, PVD, CAD, CHF, neoplasm, ability to ambulate, and education level.
Kidney International  , DOI: ( /j x)
Copyright © 2001 International Society of Nephrology Terms and Conditions

4. Figure 3
Adjusted* relative risk of death by VA types among diabetic patients. *Adjusted for age, race, gender, BMI, history of smoking, PVD, CAD, CHF, neoplasm, ability to ambulate and education level. Prevalent diabetic patients: CVC vs. AVG (P = 0.42). Incident diabetic patients: CVC vs. AVG (P = 0.48).
Kidney International  , DOI: ( /j x)
Copyright © 2001 International Society of Nephrology Terms and Conditions

5. Figure 4
Adjusted* relative risk of death by VA types among nondiabetic patients. *Adjusted for age, race, gender, BMI, history of smoking, PVD, CAD, CHF, neoplasm, ability to ambulate and education level. Prevalent nondiabetic patients: CVC vs. AVG (P < ). Incident nondiabetic patients: CVC vs. AVG (P = 0.82).
Kidney International  , DOI: ( /j x)
Copyright © 2001 International Society of Nephrology Terms and Conditions

6. Figure 5
Adjusted* relative risk of death due to cardiac causes by VA type and diabetes status. *Adjusted for age, race, gender, BMI, history of smoking, PVD, CAD, CHF, neoplasm, ability to ambulate and education level. Prevalent diabetic patients: CVC vs. AVG (P = 0.59). Prevalent nondiabetic patients: CVC vs. AVG (P = 0.003).
Kidney International  , DOI: ( /j x)
Copyright © 2001 International Society of Nephrology Terms and Conditions

7. Figure 6
Adjusted* relative risk of death due to infection by VA type and diabetes status. *Adjusted for age, race, gender, BMI, history of smoking, PVD, CAD, CHF, neoplasm, ability to ambulate and education level. Prevalent diabetic patients: CVC vs. AVG (P = 0.81). Prevalent nondiabetic patients: CVC vs. AVG (P = 0.13).
Kidney International  , DOI: ( /j x)
Copyright © 2001 International Society of Nephrology Terms and Conditions